Journal
JOURNAL OF CLINICAL GASTROENTEROLOGY
Volume 31, Issue 4, Pages 282-291Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00004836-200012000-00004
Keywords
Crohn's disease; inflammatory bowel disease; treatment
Categories
Ask authors/readers for more resources
Crohn's disease is an inflammatory bowel disorder that has no known cause. The goal of medical treatment is to control active disease, induce and maintain clinical remission, and treat complications. Anti-inflammatory medications and immunomodulatory therapies are the primary treatment modalities for Crohn's disease. The categories of standard treatment include the 5-aminosalicylic acid compounds, corticosteroids, antibiotics, and immunomodulators. New biologic therapy has been developed to better target the immune mediators that are active in Crohn's disease. Infliximab is the first of the biologic agents approved for the treatment of fistulizing and active Crohn's disease. Despite medical advances in treatment, there is still no cure for Crohn's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available